Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05788081
Title Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD BMS-986369, Rituximab +/- Nivolumab. (TOP-FLOR)
Acronym TOP-FLOR
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Olivia Newton-John Cancer Research Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Grampians Health RECRUITING Ballarat Victoria Australia Details
Eastern Health NOT_YET_RECRUITING Box Hill Victoria 3128 Australia Details
University Hospital Geelong, Barwon Health RECRUITING Geelong Victoria Australia Details
Austin Health RECRUITING Heidelberg Victoria 3078 Australia Details
Fiona Stanley Hospital NOT_YET_RECRUITING Perth Western Australia Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field